Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17407186 | 0.89 | TSHR (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL2721270 | 0.88 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL20956850 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| Ethylene SCHEMBL28738416 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL1337099 | 0.86 | THRB (0.57) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13144408 | 0.85 | THRB (0.45) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL13618829 | 0.84 | TSHR (0.46) | THRBTSHRALDH1A1POLBAPEX1 | |
| Butane SCHEMBL17350368 | 0.83 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL15636 | 0.82 | THRB (0.74) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL6142874 | 0.82 | THRB (0.74) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9890264-B2 | Metal oxide dispersion, polymerizable composition comprising the metal oxide dispersion, and polymer thereof | OSAKA RESEARCH INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9845394-B2 | Method for producing thin film having high refractive index and high transparency, and thin film produced by the method | OSAKA MUNICIPAL TECHNICAL RESEARCH INSTITUTE (JP) | 2017-12-19 | — | — | US | disclosed |
| US-20170151158-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2017-06-01 | — | — | US | disclosed |
| US-20160338938-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160331668-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160331651-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160331667-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160331665-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160331669-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160331670-A1 | ORAL CARE COMPOSITIONS AND METHODS | COLGATE PALMOLIVE CO (US) | 2016-11-17 | — | — | US | disclosed |
| US-20080241754-A1 | POLYONIUM BORATES AND RADIATION-SENSITIVE COMPOSITION AND IMAGEABLE ELEMENTS CONTAINING SAME | BANK OF AMERICA, N.A., AS AGENT | 2008-10-02 | — | — | US | disclosed |
| US-7429445-B1 | Negative-working imageable elements and methods of use | EASTMAN KODAK COMPANY (US) | 2008-09-30 | — | — | US | disclosed |
| US-20080220365-A1 | NEGATIVE-WORKING IMAGEABLE ELEMENTS AND METHODS OF USE | FAR EAST DEVELOPMENT LTD. | 2008-09-11 | — | — | US | disclosed |
| US-20080064233-A1 | CIRCUIT-CONNECTING MATERIAL AND CIRCUIT TERMINAL CONNECTED STRUCTURE AND CONNECTING METHOD | HITACHI CHEMICAL CO., LTD. (JP) | 2008-03-13 | — | — | US | disclosed |
| US-20080054225-A1 | interposed between circuit electrodes facing each other and electrically connects the electrodes in the pressing direction by pressing the facing electrodes against each other; the circuit-connecting material comprising as essential components, a curing agent and a hydroxy resin with radical polymer | HITACHI CHEMICAL CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| US-20080057742-A1 | CIRCUIT-CONNECTING MATERIAL AND CIRCUIT TERMINAL CONNECTED STRUCTURE AND CONNECTING METHOD | HITACHI CHEMICAL CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| US-20080008957-A1 | Negative-working radiation-sensitive compositions and imageable elements | EASTMAN KODAK COMPANY | 2008-01-10 | — | — | US | disclosed |
| US-20070299172-A1 | interposed between circuit electrodes facing each other and electrically connects the electrodes in the pressing direction by pressing the facing electrodes against each other; the circuit-connecting material comprising as essential components, a curing agent and a hydroxy resin with radical polymer | HITACHI CHEMICAL CO., LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
| US-7241644-B2 | Adhesive, method of connecting wiring terminals and wiring structure | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2007-07-10 | — | — | US | disclosed |
| US-7175969-B1 | Method of preparing negative-working radiation-sensitive elements | EASTMAN KODAK COMPANY (US) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331667-A1 | ORAL CARE COMPOSITIONS AND METHODS | ALG1, FHIT, TAS2R39 | THRB 3993/4885TSHR 4605/4885ALDH1A1 3813/4885 |
| US-20160331668-A1 | ORAL CARE COMPOSITIONS AND METHODS | TAS2R40, TAS2R39, TAS2R30 | THRB 3739/4885TSHR 4431/4885ALDH1A1 2353/4885 |
| US-20160331669-A1 | ORAL CARE COMPOSITIONS AND METHODS | TAS2R39, TAS2R40, TAS2R9 | THRB 1889/4885TSHR 2713/4885ALDH1A1 4457/4885 |
| US-20080241754-A1 | POLYONIUM BORATES AND RADIATION-SENSITIVE COMPOSITION AND IMAGEABLE ELEMENTS CONTAINING SAME | XRCC5, BRAP, BRI3BP | THRB 2146/4885TSHR 3303/4885ALDH1A1 4884/4885 |
| US-20170151158-A1 | Oral Care Compositions | ARG1, SRM, ODC1 | THRB 4127/4885TSHR 4381/4885ALDH1A1 4346/4885 |
| US-20160338938-A1 | ORAL CARE COMPOSITIONS AND METHODS | SLC39A7, SLC39A3, SLC30A7 | THRB 3947/4885TSHR 4460/4885ALDH1A1 3659/4885 |
| US-20160331651-A1 | ORAL CARE COMPOSITIONS AND METHODS | ALG1, RPN1, TAS2R39 | THRB 3247/4885TSHR 4500/4885ALDH1A1 2891/4885 |
| US-20160331665-A1 | ORAL CARE COMPOSITIONS AND METHODS | TAS2R40, TAS2R39, TAS2R45 | THRB 926/4885TSHR 954/4885ALDH1A1 4539/4885 |
| US-20160331670-A1 | ORAL CARE COMPOSITIONS AND METHODS | ALG1, TAS2R39, KRTCAP2 | THRB 3437/4885TSHR 4264/4885ALDH1A1 4424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.